Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
25.23
-0.41 (-1.60%)
Nov 21, 2024, 11:34 AM EST - Market open
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $1.73 billion as of November 21, 2024. Its market cap has decreased by -31.09% in one year.
Market Cap
1.73B
Enterprise Value
-1.77B
1-Year Change
-31.09%
Ranking
Category
Stock Price
$25.23
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has decreased from $1.86B to $1.73B, a decrease of -7.25%. That is a compound annual growth rate of -0.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.76B | -34.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MannKind | 1.85B |
| Patterson Companies | 1.84B |
| Azenta | 1.84B |
| Structure Therapeutics | 1.82B |
| RxSight | 1.80B |
| Recursion Pharmaceuticals | 1.75B |
| Integra LifeSciences Holdings | 1.74B |
| Disc Medicine | 1.71B |